Clinical Study of KN052 in Chinese Subjects With Advanced Solid Tumors
Clinical trial NCT05309512 · TERMINATED
Trial details
- NCT number
- NCT05309512
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-27
- Primary completion
- 2023-11-14
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.